These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6116954)

  • 1. Haemodynamic effects of beta-blockade in ischaemic heart failure.
    Taylor SH; Silke B
    Lancet; 1981 Oct; 2(8251):835-7. PubMed ID: 6116954
    [No Abstract]   [Full Text] [Related]  

  • 2. [Potential possibilities of using adrenergic beta blockers in chronic heart failure].
    Lopatin IuM; Ghani P; Sinitsin VE; Mareev VIu
    Kardiologiia; 1992 Mar; 32(3):79-82. PubMed ID: 1405223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Right ventricular performance in essential hypertension after beta-blockade.
    Ferlinz J; Easthope JL; Hughes D; Siegel J; Tobis J; Aronow WS
    Br Heart J; 1981 Jul; 46(1):23-9. PubMed ID: 7023516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of chronic heart failure with pirbuterol: acute haemodynamic responses.
    Dawson JR; Canepa-Anson R; Kuan P; Whitaker NH; Carnie J; Warnes C; Reuben SR; Poole-Wilson PA; Sutton GC
    Br Med J (Clin Res Ed); 1981 May; 282(6274):1423-6. PubMed ID: 6112039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and chronic effects of oral hydralazine on left ventricular pump function and renal hemodynamics in chronic left heart failure.
    Mathey D; Hanrath P; Polster J; Witte G; Montz R; Bleifeld W
    Eur Heart J; 1980 Feb; 1(1):25-9. PubMed ID: 7285964
    [No Abstract]   [Full Text] [Related]  

  • 6. Haemodynamic and myocardial metabolic effects of captopril in chronic heart failure.
    Chatterjee K; Rouleau JL; Parmley WW
    Br Heart J; 1982 Mar; 47(3):233-8. PubMed ID: 7037025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive and hemodynamic effects of oxprenolol versus propranolol.
    Ferlinz J; Easthope JL; Hughes D; Siegel J; Tobis J; Aronow WS
    Clin Pharmacol Ther; 1980 Jun; 27(6):733-43. PubMed ID: 6991196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of adrenoreactive preparations on clinical and haemodynamic parameters in patients with ischaemic heart disease.
    Piatak OA; Yanovskii GV; Lizogub VG
    Cor Vasa; 1991; 33(1):19-25. PubMed ID: 1655353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term beta-blockade: prolonged protective action on the ischaemic myocardium.
    Manning AS; Keogh JM; Shattock MJ; Coltart DJ; Hearse DJ
    Cardiovasc Res; 1981 Aug; 15(8):462-7. PubMed ID: 7307031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular function and beta-blockade in chronic ischaemic heart failure. Double-blind, cross-over study of propranolol and penbutolol using non-invasive techniques.
    Vedin A; Wikstrand J; Wilhelmsson C; Wallentin I
    Br Heart J; 1980 Jul; 44(1):101-7. PubMed ID: 7000099
    [No Abstract]   [Full Text] [Related]  

  • 11. Haemodynamic effects of intravenous isosorbide-5-mononitrate in acute and chronic left heart failure of ischaemic aetiology.
    Rabinowitz B; Katz A; Shotan A; Chouraqui P; Neufeld HN
    Eur Heart J; 1988 Jan; 9 Suppl A():175-80. PubMed ID: 3409914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise performance in mildly hypertensive patients. Impairment by propranolol but not oxprenolol.
    Franciosa JA; Johnson SM; Tobian LJ
    Chest; 1980 Aug; 78(2):291-9. PubMed ID: 6995041
    [No Abstract]   [Full Text] [Related]  

  • 13. Beta blockade in congestive heart failure: persistent adverse haemodynamic effects during chronic treatment with subsequent doses.
    Kukin ML; Kalman J; Mannino MM; Buchholz-Varley C; Ocampo O
    Heart; 1997 Nov; 78(5):444-9. PubMed ID: 9415001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind trial of chronic oral beta blockade in congestive cardiomyopathy.
    Ikram H; Fitzpatrick D
    Lancet; 1981 Sep; 2(8245):490-3. PubMed ID: 6115247
    [No Abstract]   [Full Text] [Related]  

  • 15. Haemodynamic effects of slow-release nifedipine in severe congestive heart failure due to ischaemic heart disease.
    Rossi A; Ziacchi V
    Cardiology; 1990; 77(6):450-8. PubMed ID: 2073662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of lisinopril on cardiac remodeling in patients with cardiosclerosis after myocardial infarction and signs of chronic heart failure].
    Blagodar VN; Petriĭ VV; Makolkin VI
    Kardiologiia; 2003; 43(9):17-20. PubMed ID: 14682288
    [No Abstract]   [Full Text] [Related]  

  • 17. Phentolamine for vasodilator treatment of severe heart-failure.
    Majid PA; Sharma B; Taylor SH
    Lancet; 1971 Oct; 2(7727):719-24. PubMed ID: 4106226
    [No Abstract]   [Full Text] [Related]  

  • 18. Haemodynamic dose-response effects of UK-52,046 in ischaemic disease with or without impaired left ventricular function.
    Silke B; Zezulka AV; Verma SP; Tham TC; Taylor SH
    Br J Clin Pharmacol; 1990 Jun; 29(6):749-58. PubMed ID: 1974144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of glucagon on the left ventricular function in patients with congestive heart failure (author's transl)].
    Dubiel JS; Pyzik A; Szczeklik J; Dubiel JP; Cibor E
    Przegl Lek; 1975; 32(8):662-8. PubMed ID: 1162130
    [No Abstract]   [Full Text] [Related]  

  • 20. Haemodynamic effects of intravenous isosorbide dinitrate in patients of cardiac failure following acute myocardial infarction.
    Pande AK; Ambardekar SS; Kumar A; Tulpule AT; Goyal BK
    Indian Heart J; 1985; 37(6):339-42. PubMed ID: 3836934
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.